HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

Glasgow Precision Oncology Laboratory, Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, Rosie Upstill-Goddard, Ulla-Maja Bailey, Ian M Garner, Craig Nourse, Stephan Dreyer, Marc Jones, Kim Moran-Jones, Derek W Wright, Viola Paulus-Hock, Colin Nixon, Gemma Thomson, Nigel B Jamieson, Grant A McGregor, Lisa Evers, Colin J McKay, Aditi GulatiRachel Brough, Ilirjana Bajrami, Stephen J Pettitt, Michele L Dziubinski, Simon T Barry, Robert Grützmann, Robert Brown, Edward Curry, Marina Pajic, Elizabeth A Musgrove, Gloria M Petersen, Emma Shanks, Alan Ashworth, Howard C Crawford, Diane M Simeone, Fieke E M Froeling, Christopher J Lord, Debabrata Mukhopadhyay, Christian Pilarsky, Sean E Grimmond, Jennifer P Morton, Owen J Sansom, David K Chang, Peter J Bailey, Andrew V Biankin

Onderzoeksoutput: Articlepeer review

81 Citaten (Scopus)
98 Downloads (Pure)

Vingerafdruk

Duik in de onderzoeksthema's van 'HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer'. Samen vormen ze een unieke vingerafdruk.

Medicine & Life Sciences

Chemistry